Mesa Laboratories (MLAB) Asset Writedowns and Impairment (2017 - 2019)

Mesa Laboratories has reported Asset Writedowns and Impairment for 3 years, with the latest figure at $276000.0 in Q4 2019.

• Quarterly Asset Writedowns and Impairment fell 92.48% year-over-year to $276000.0 in Q4 2019, while the trailing twelve-month figure through Mar 2020 was $5.0 million (down 72.84% YoY) and the FY2024 annual result came in at $274.5 million, changed N/A from the prior year.
• Asset Writedowns and Impairment declined to $276000.0 in Q4 2019 per MLAB's latest filing, from $1.1 million in the prior quarter.
• Over five years, Asset Writedowns and Impairment peaked at $13.8 million in Q4 2017 and troughed at $276000.0 in Q4 2019.
• A 3-year average of $4.7 million and a median of $2.4 million in 2018 frame the typical range for Asset Writedowns and Impairment.
• The sharpest annual moves came in 2018 and 2019: Asset Writedowns and Impairment sank 73.45% in 2018, then sank 92.48% in 2019.
• Over 3 years, Asset Writedowns and Impairment stood at $13.8 million in 2017, then tumbled by 73.45% to $3.7 million in 2018, then tumbled by 92.48% to $276000.0 in 2019.
• According to Business Quant data, Asset Writedowns and Impairment over the past three periods registered $276000.0, $1.1 million, and $3.7 million for Q4 2019, Q1 2019, and Q4 2018 respectively.